Egetis Therapeutics AB (publ) (OM:EGTX) said on May 23, 2023 Egetis announced termination of discussions regarding potential acquisition of co. Discussions have now been terminated as board believes contemplated offer, terms, while providing premium to current share price, considerably undervalued long-term prospects of company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 SEK | +8.69% | +1.59% | +14.34% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.34% | 157M | |
-3.00% | 102B | |
+1.95% | 96.29B | |
+2.13% | 22.18B | |
-15.36% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.29% | 16.36B | |
+5.13% | 13.97B | |
+33.11% | 12.17B |
- Stock Market
- Equities
- EGTX Stock
- News Egetis Therapeutics AB
- Egetis Terminates Discussions Regarding Potential Acquisition